Biotech acquisitions by big pharma: why and what is next.
Leading pharmaceutical companies are increasingly making biotech acquisitions to help them refill their pipelines, but what makes a good acquisition target and what will be the impact of the present financial crisis on deals.
Malik
Nafees N
NN
Institute of Biotechnology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QT, UK. nafees_malik@hotmail.com
D001709:Biotechnology / Q000191:economics / Q000639:trends*; D055808:Drug Discovery / Q000191:economics / Q000639:trends*; D004345:Drug Industry / Q000191:economics*